A state-controlled company Sinopharm said its candidate had a 79 percent efficacy rate in the interim late-stage trials. A volunteer received the Sinopharm vaccine during a trial at the Clinical Studies Center of the Cayetano Heredia University in Lima, Peru, in December 2020. Chinese company Sinopharm launches new vaccine A Chinese pharmaceutical company stated that...